Outcome of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts less than Nifty Microcap 250 and 2.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board of Jaysynth Orgochem met on 10th February 2026 and approved the unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December 2025, along with the limited review report from statutory auditor M/s. AHJ & Associates. The board also approved the redemption of 6 crore (6,00,00,000) 2% Redeemable Non-convertible Non-cumulative Non-participating Preference Shares of Rs 1 each, aggregating to Rs 600 lakhs, along with dividend up to the redemption date. The redemption will be completed on 31st March 2026 and will be funded entirely from the company's accumulated profits. This is a routine quarterly board outcome combined with a pre-scheduled capital restructuring action.
Marginally positive for shareholders — the preference share redemption is being funded from accumulated profits (not fresh borrowing), simplifies the capital structure, and removes a small 2% non-cumulative preference obligation. No change in equity capital since these are preference shares, not equity shares.